https://www.selleckchem.com/pr....oducts/navoximod.htm
11 doses/patient, .0001, = 27.445) and LC (9 doses/patient . 10 doses/patient, .0001, = 9.911) cohorts. Patients of the RC cohort had less time to first drink, first bowel movement, full diet, and hospital stay than those of NS and LC cohorts ( .05 and 3.329 for all). Pre-, peri-, and postoperative intravenous ropivacaine are safe and effective than that of normal saline or lidocaine in hand-assisted laparoscopic surgery of left colon cancer. Pre-, peri-, and postoperative intravenous ropivacaine are safe and
Like
Comment
Share
